# Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial

> **NCT06267300** · PHASE3 · UNKNOWN · sponsor: **Erasmus Medical Center** · enrollment: 120 (estimated)

## Conditions studied

- Post-COVID-19 Syndrome
- Post-COVID Syndrome
- Post COVID-19 Condition
- Post-COVID Condition
- Post COVID-19 Condition, Unspecified
- Long COVID
- Long Covid19

## Interventions

- **DRUG:** Hyperbaric oxygen

## Key facts

- **NCT ID:** NCT06267300
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-10-01
- **Primary completion:** 2025-10-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06267300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06267300, "Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06267300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*